Most ultra-expensive drugs in USA provide low added benefit

This is a preview of subscription content, access via your institution.

Notes

  1. 1.

    2018 US dollars

Reference

  1. DiStefano MJ, et al. Assessing the Added Therapeutic Benefit of Ultra-Expensive Drugs. Value in Health : 6 Jan 2021. Available from: URL: https://doi.org/10.1016/j.jval.2020.10.021

Download references

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Most ultra-expensive drugs in USA provide low added benefit. PharmacoEcon Outcomes News 870, 15 (2021). https://doi.org/10.1007/s40274-021-7418-4

Download citation